---
figid: PMC2580829__nihms75391f8
figlink: /pmc/articles/PMC2580829/figure/F8/
number: Fig. 8
caption: Hypothetical model for AVP concentration-dependent transitions between Ca2+
  entry and Ca2+ release. Picomolar AVP concentrations induce voltage-sensitive Ca2+
  entry via PKC activation and inhibition of voltage-activated K+ channels (Kv) (light
  shaded box). Nanomolar concentrations of AVP acutely activate the well-established
  AVP signaling pathway, which is dependent on phospholipase C (PLC) activation and
  inositol 1,4,5-trisphosphate (IP3)-mediated Ca2+ release (dark shaded box). Prolonged
  nanomolar AVP stimulation (30 min) activates nonselective cation channels (NSCC),
  via diacylglycreol (DAG), which leads to membrane depolarization (ΔEm) and voltage-sensitive
  Ca2+ entry. Inhibition of PKC would block downstream signaling pathways (dashed
  lines). V1a, V1a vasopressin receptor; PLD, phospholipase D; VSCC, voltage-sensitive
  L-type Ca2+ channels; Gq, G protein alpha q subunit.
pmcid: PMC2580829
papertitle: 'Vasopressin-induced vasoconstriction: two concentration-dependent signaling
  pathways.'
reftext: Kyle K. Henderson, et al. J Appl Physiol. ;102(4):1402-1409.
pmc_ranked_result_index: '90684'
pathway_score: 0.9408266
filename: nihms75391f8.jpg
figtitle: Hypothetical model for AVP concentration-dependent transitions between Ca2+
  entry and Ca2+ release
year: ''
organisms: Homo sapiens
ndex: 621341ff-deb4-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2580829__nihms75391f8.html
  '@type': Dataset
  description: Hypothetical model for AVP concentration-dependent transitions between
    Ca2+ entry and Ca2+ release. Picomolar AVP concentrations induce voltage-sensitive
    Ca2+ entry via PKC activation and inhibition of voltage-activated K+ channels
    (Kv) (light shaded box). Nanomolar concentrations of AVP acutely activate the
    well-established AVP signaling pathway, which is dependent on phospholipase C
    (PLC) activation and inositol 1,4,5-trisphosphate (IP3)-mediated Ca2+ release
    (dark shaded box). Prolonged nanomolar AVP stimulation (30 min) activates nonselective
    cation channels (NSCC), via diacylglycreol (DAG), which leads to membrane depolarization
    (ΔEm) and voltage-sensitive Ca2+ entry. Inhibition of PKC would block downstream
    signaling pathways (dashed lines). V1a, V1a vasopressin receptor; PLD, phospholipase
    D; VSCC, voltage-sensitive L-type Ca2+ channels; Gq, G protein alpha q subunit.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PLCB3
  - PLCB2
  - AVP
  - PLD6
  - PLCB4
  - PLCE1
  - PLD5
  - PLCD1
  - PLCB1
  - PRKCE
  - PLD1
  - PRKCG
  - PRKCB
  - PLCD3
  - PLD2
  - PLD3
  - PRKCZ
  - PLCG1
  - PRKCQ
  - PLD4
  - PRKD3
  - PRKCH
  - PRKCD
  - PLCZ1
  - PLCG2
  - PRKCI
  - PRKCA
  - PLCD4
genes:
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB3
  entrez: '5331'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB2
  entrez: '5330'
- word: AVP
  symbol: AVP
  source: hgnc_symbol
  hgnc_symbol: AVP
  entrez: '551'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD6
  entrez: '201164'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB4
  entrez: '5332'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCE1
  entrez: '51196'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD5
  entrez: '200150'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD1
  entrez: '5333'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCB1
  entrez: '23236'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCE
  entrez: '5581'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD1
  entrez: '5337'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCG
  entrez: '5582'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCB
  entrez: '5579'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD3
  entrez: '113026'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD2
  entrez: '5338'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD3
  entrez: '23646'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCZ
  entrez: '5590'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCQ
  entrez: '5588'
- word: PLD
  symbol: PLD
  source: bioentities_symbol
  hgnc_symbol: PLD4
  entrez: '122618'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKD3
  entrez: '23683'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCH
  entrez: '5583'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCD
  entrez: '5580'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCZ1
  entrez: '89869'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCI
  entrez: '5584'
- word: PKC
  symbol: PKC
  source: bioentities_symbol
  hgnc_symbol: PRKCA
  entrez: '5578'
- word: PLC
  symbol: PLC
  source: bioentities_symbol
  hgnc_symbol: PLCD4
  entrez: '84812'
chemicals: []
diseases: []
---
